NTRK Gene Fusion Enrichment in Patient Subpopulations

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, identify specific subpopulations of patients in which NTRK gene fusions may be commonly uncovered.

Related Videos

December 18, 2018

Financial Constraints to Molecular Biomarker Testing

Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.

January 20, 2016

Which Stem Cell Properties Drive Which Cancers?

Dr Wainberg and Dr Gerson review the characteristics of these stem cells, what some of the medicines are doing right now, and some of the expectations in future clinical trials.